The diabetic cardiomyopathy

Acta Diabetologica

Volumn 48, Issue 3, 2011, Pages 173-181

  Tarquini, Roberto ^a   Lazzeri, Chiara ^a   Pala, Laura ^a   Rotella, Carlo Maria ^a   Gensini, Gian Franco ^a  

^a CAREGGI UNIVERSITY HOSPITAL   (Italy)

Author keywords

Diabetic cardiomyopathy; Pathophysiology; Prognosis

Indexed keywords

AUTONOMIC NEUROPATHY; CALCIUM HOMEOSTASIS; CARDIOVASCULAR RISK; CORONARY ARTERY DISEASE; DIABETIC CARDIOMYOPATHY; ECHOCARDIOGRAPHY; EPIDEMIOLOGICAL DATA; HEART FAILURE; HIGH RISK PATIENT; HUMAN; HYPERGLYCEMIA; HYPERTENSION; IDIOPATHIC DISEASE; INSULIN DEPENDENT DIABETES MELLITUS; METABOLIC DISORDER; MICROALBUMINURIA; MYOCARDIAL DISEASE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OXIDATIVE STRESS; PREVALENCE; PRIORITY JOURNAL; REVIEW; SCREENING; VALVULAR HEART DISEASE;

ANIMALS; CARDIOVASCULAR SYSTEM; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; DIABETIC CARDIOMYOPATHIES; DISEASE MODELS, ANIMAL; HUMANS;

EID: 80052355062     PISSN: 09405429     EISSN: 14325233     Source Type: Journal    
DOI: 10.1007/s00592-010-0180-x     Document Type: Review

References (84)

1. A Aneja WH Tang S Bansilal MJ Garcia ME Farkouh 2008 Diabetic cardiomyopathy: insights into pathogenesis, diagnostic challenges, and therapeutic options Am J Med 121 9 748 757 18724960 10.1016/j.amjmed.2008.03.046
2. ZY Fang JB Prins TH Marwick 2004 Diabetic cardiomyopathy: evidence, mechanisms, and therapeutic implications Endocr Rev 25 4 543 567 15294881 10.1210/er.2003-0012 1:CAS:528:DC%2BD2cXns1Ghtrc%3D (Pubitemid 39096070)
3. S Rubler J Dlugash YZ Yuceoglu T Kumral AW Branwood A Grishman 1972 New type of cardiomyopathy associated with diabetic glomerulosclerosis Am J Cardiol 30 6 595 602 4263660 10.1016/0002-9149(72)90595-4 1:STN:280: DyaE3s%2FjtFeksA%3D%3D
4. TJ Regan MM Lyons SS Ahmed GE Levinson HA Oldewurtel MR Ahmad B Haider 1977 Evidence for cardiomyopathy in familial diabetes mellitus J Clin Invest 60 4 884 899 893679 10.1172/JCI108843 1:STN:280:DyaE2s3ltVSmtw%3D%3D
5. GA Nichols TA Hillier JR Erbey JB Brown 2001 Congestive heart failure in type 2 diabetes: prevalence, incidence, and risk factors Diabetes Care 24 9 1614 1619 11522708 10.2337/diacare.24.9.1614 1:STN:280:DC%2BD3MvnvV2mug%3D%3D (Pubitemid 33716458)
6. WB Kannel DL McGee 1979 Diabetes and cardiovascular disease. The Framingham study JAMA 241 19 2035 2038 430798 10.1001/jama.241.19.2035 1:STN:280:DyaE1M7lsVCksg%3D%3D (Pubitemid 9228506)
7. SA Hunt American College of Cardiology; American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation, Management of Heart Failure) 2005 ACC/AHA 2005 guideline update for the diagnosis and management of chronic heart failure in the adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure) JACC 46 6 e1 e82 16168273
8. IM Stratton AI Adler HA Neil JS Yudkin DR Matthews CA Cull, et al. 2000 Association of glycemia with macrovascular and microvascular complications of type 2 diabetes (United Kingdom Prospective Diabetes Study 35): prospective observational study BMJ 321 405 412 10938048 10.1136/bmj.321.7258.405 1:STN:280:DC%2BD3cvisFWnsg%3D%3D (Pubitemid 30609442)
9. AG Bertoni A Tsai EK Kasper FL Brancati 2003 Diabetes and idiopathic cardiomyopathy: a nationwide case-control study Diabetes Care 26 10 2791 2795 14514581 10.2337/diacare.26.10.2791 (Pubitemid 37205548)
10. AG Bertoni WG Hundley MW Massing DE Bonds GL Burke DC Goff Jr. 2004 Heart failure prevalence, incidence, and mortality in the elderly with diabetes Diabetes Care 27 699 703 14988288 10.2337/diacare.27.3.699 (Pubitemid 38280536)
11. WB Kannel DL McGee 1979 Diabetes and cardiovascular disease: the Framingham study JAMA 241 2035 2038 430798 10.1001/jama.241.19.2035 1:STN:280:DyaE1M7lsVCksg%3D%3D (Pubitemid 9228506)
12. IG Poornima P Parikh RP Shannon 2006 Diabetic cardiomyopathy: the search for a unifying hypothesis Circ Res 98 5 596 605 16543510 10.1161/01.RES. 0000207406.94146.c2 1:CAS:528:DC%2BD28XitFOiurY%3D
13. GX Liu PJ Hanley J Ray J Daut 2001 Long-chain acyl-coenzyme A esters and fatty acids directly link metabolism to K (ATP) channels in the heart Circ Res 88 9 918 924 11349001 10.1161/hh0901.089881 1:CAS:528:DC%2BD3MXjs1Gitr8%3D (Pubitemid 32441470)
14. S Boudina ED Abel 2006 Mitochondrial uncoupling: a key contributor to reduced cardiac efficiency in diabetes Physiology 21 250 258 16868314 10.1152/physiol.00008.2006 1:CAS:528:DC%2BD28XpsVCitbg%3D (Pubitemid 44156857)
15. JM McGavock I Lingvay I Zib T Tillery N Salas R Unger, et al. 2007 Cardiac steatosis in diabetes mellitus: a 1H-magnetic resonance spectroscopy study Circulation 116 1170 1175 17698735 10.1161/CIRCULATIONAHA.106.645614 (Pubitemid 47360218)
16. LJ Rijzewijk RW van der Meer JW Smit M Diamant JJ Bax S Hammer, et al. 2008 Myocardial steatosis is an independent predictor of diastolic dysfunction in type 2 diabetes mellitus Am Coll Cardiol 52 22 1793 1799 10.1016/j.jacc.2008. 07.062
17. P Herrero LR Peterson JB McGill S Matthew D Lesniak C Dence, et al. 2006 Increased myocardial fatty acid metabolism in patients with type 1 diabetes mellitus J Am Coll Cardiol 47 598 604 16458143 10.1016/j.jacc.2005.09.030 1:CAS:528:DC%2BD28XhtVGjsLg%3D (Pubitemid 43170851)
18. LR Peterson P Herrero KB Schechtman SB Racette AD Waggoner Z Kisrieva-Ware, et al. 2004 Effect of obesity and insulin resistance on myocardial substrate metabolism and efficiency in young women Circulation 109 2191 2196 15123530 10.1161/01.CIR.0000127959.28627.F8 (Pubitemid 38625396)
19. BT O'Neill ED Abel 2005 Akt1 in the cardiovascular system: friend or foe? J Clin Invest 115 2059 2064 16075047 10.1172/JCI25900 (Pubitemid 41134142)
20. W Kern A Peters J Born HL Fehm B Schultes 2005 Changes in blood pressure and plasma catecholamine levels during prolonged hyperinsulinemia Metabolism 54 391 396 15736119 10.1016/j.metabol.2004.10.005 1:CAS:528:DC%2BD2MXhsVOjtbs%3D (Pubitemid 40250101)
21. Z Naito E Takashi G Xu T Ishiwata K Teduka M Yokoyama, et al. 2003 Different influences of hyperglycemic duration on phosphorylated extracellular signal-regulated kinase 1/2 in rat heart Exp Mol Pathol 74 23 32 12645629 10.1016/S0014-4800(03)80005-9 1:CAS:528:DC%2BD3sXhtlOhsLk%3D (Pubitemid 41264487)
22. X Du T Matsumura D Edelstein L Rossetti Z Zsengeller C Szabo M Brownlee 2003 Inhibition of GAPDH activity by poly(ADP-ribose) polymerase activates three major pathways of hyperglycemic damage in endothelial cells J Clin Invest 112 1049 1057 14523042 1:CAS:528:DC%2BD3sXnvFGrsLY%3D (Pubitemid 38056320)
23. BK Kilhovd TJ Berg KI Birkeland P Thorsby KF Hanssen 1999 Serum levels of advanced glycation end products are increased in patients with type 2 diabetes and coronary heart disease Diabetes Care 22 9 1543 1548 10480523 10.2337/diacare.22.9.1543 1:STN:280:DyaK1MvgvVCjsg%3D%3D (Pubitemid 29418253)
24. Antonio Ceriello, Michael A. Ihnat, Jessica E (2009) Thorpe. The "metabolic memory": is more than just tight glucose control necessary to prevent diabetic complications?. J Clin Endocrinol Metab 410-415
25. Mannucci E, Ognibene A, Cremasco F, Bardini G, Mencucci A, Pierazzuoli E, Ciani S, Fanelli A, Messeri G, Rotella CM (2000) Glucagon-like peptide (GLP)-1 and leptin concentrations in obese patients with Type 2 diabetes mellitus. Diabet Med 713-719
26. E Mannucci L Pala S Ciani G Bardini A Pezzatini I Sposato F Cremasco A Ognibene CM Rotella 2005 Hyperglycaemia increases dipeptidyl peptidase IV activity in diabetes mellitus Diabetologia 48 6 1168 1172 15864535 10.1007/s00125-005-1749-8 1:CAS:528:DC%2BD2MXlt1Kmt7s%3D (Pubitemid 40909653)
27. CM Rotella E Mannucci 2008 Future perspectives on glucagon-like peptide-1, diabetes and cardiovascular risk Nutr Metab Cardiovasc Dis 18 639 645 18849155 10.1016/j.numecd.2008.08.002
28. JM Barragan RE Rodriguez E Blazquez 1994 Changes in arterial blood pressure and heart rate induced by glucagon-like peptide-1 (7-36) amide in rats Am J Physiol 266 E459e66
29. H Yamamoto CE Lee JN Marcus TD Williams JM Overton ME Lopez, et al. 2002 Glucagon-like peptide-1 receptor stimulation increases blood pressure and heart rate and activates autonomic regulatory neurons J Clin Invest 110 43e52
30. C Saraceni TL Broderick 2007 Effects of glucagon-like peptide-1 and long-acting analogues on cardiovascular and metabolic function Drugs R D 8 145 153 17472410 10.2165/00126839-200708030-00002 1:CAS:528:DC%2BD2sXntVSnsr0%3D (Pubitemid 46707838)
31. E Bojanowska B Stempniak 2009 Effects of centrally or systematically injected glucagon-like peptide-1(7-36) amide in rats Regul Pept 91 75 81 10.1016/S0167-0115(00)00119-1
32. SM Gardiner JE March PA Kemp T Bennett 2006 Mesenteric vasoconstriction and hindquarters vasodilation accompany the pressor actions of exendin-4 in conscious rats J Pharmacol Exp Ther 316 852 859 16221740 10.1124/jpet.105.093104 1:CAS:528:DC%2BD28XhtlWqt7k%3D (Pubitemid 43131015)
33. RE Amori J Lau AG Pittas 2007 Efficacy and safety of incretin therapy in type 2 diabetes. Systematic review and metaanalysis JAMA 298 194 206 17622601 10.1001/jama.298.2.194 1:CAS:528:DC%2BD2sXnslSjuro%3D (Pubitemid 47057766)
34. DJ Drucker MA Nauck 2006 The incretin system: glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes Lancet 318 1696 1705 10.1016/S0140-6736(06)69705-5 (Pubitemid 46048557)
35. SE Inzucchi DK McGuire 2008 New drugs for the treatment of diabetes. Part II: incretin-based therapy and beyond Circulation 117 574 584 18227398 10.1161/CIRCULATIONAHA.107.735795
36. T Vilsbøll 2007 Liraglutide: a once-daily GLP-1 analogue for the treatment of type 2 diabetes mellitus Exp Opin Invest Drug 16 231 237 10.1517/13543784.16.2.231 (Pubitemid 46206637)
37. LA Nikolaidis D Elahi YT Shen RP Shannon 2005 Active metabolite of GLP-1 mediates myocardial glucose uptake and improved left ventricular performance in conscious dogs with dilated cardiomyopathy Am J Physiol Heart Circ Physiol 289 H2401 H2408 16024574 10.1152/ajpheart.00347.2005 1:CAS:528: DC%2BD28XlslGnug%3D%3D (Pubitemid 41698549)
38. DP Sonne T Engstrom M Treiman 2008 Protective effects of GLP-1 analogues exendin 4 and GLP-1(9-36)amide against ischemia reperfusion in rat heart Regul Pept 146 243 249 17976835 10.1016/j.regpep.2007.10.001 1:CAS:528: DC%2BD1cXosFKnsw%3D%3D
39. K Ban MH Noyan-Ashraf J Hoefer SS Bolz DJ Drucker M Husain 2008 Cardioprotective and vasodilatory actions of glucagon-like peptide-1 are mediated through both glucagon like peptide-1 receptor-dependent and independent pathways Circulation 117 2340 2350 18427132 10.1161/CIRCULATIONAHA.107.739938 1:CAS:528:DC%2BD1cXltFyltrY%3D (Pubitemid 351653542)
40. GG Sokos LA Nikolaidis S Mankad D Elahi RP Shannon 2006 Glucagon-like peptide-1 infusion improves left ventricular ejection fraction and functional status in patients with chronic heart failure J Card Fail 12 694 699 17174230 10.1016/j.cardfail.2006.08.211 1:CAS:528:DC%2BD28XhtlaqsrzK (Pubitemid 44881367)
41. LA Nikolaidis S Mankad GG Sokos G Miske A Shah D Elahi, et al. 2004 Effects of glucagon-like peptide-1 in patients with acute myocardial infarction and left ventricular dysfunction after successful reperfusion Circulation 109 962 965 14981009 10.1161/01.CIR.0000120505.91348.58 1:CAS:528: DC%2BD2cXhsFeisbY%3D (Pubitemid 38282847)
42. ME Young PH Guthrie P Razeghi B Leighton S Abbasi S Patil, et al. 2002 Impaired long-chain fatty acid oxidation and contractile dysfunction in the obese Zucker rat heart Diabetes 51 2587 2595 12145175 10.2337/diabetes.51.8.2587 1:CAS:528:DC%2BD38XlvFKhsrY%3D (Pubitemid 34827411)
43. B Huisamen M van Zyl A Keyser A Lochner 2001 The effects of insulin and beta-adrenergic stimulation on glucose transport, glut 4 and PKB activation in the myocardium of lean and obese noninsulin dependent diabetes mellitus rats Mol Cell Biochem 223 15 25 11681717 10.1023/A:1017528402205 1:CAS:528: DC%2BD3MXnslGnsrg%3D (Pubitemid 32952087)
44. JC Chatham AM Seymour 2002 Cardiac carbohydrate metabolism in Zucker diabetic fatty rats Cardiovasc Res 55 104 112 12062713 10.1016/S0008-6363(02) 00399-1 1:CAS:528:DC%2BD38XksVSit7g%3D (Pubitemid 34615944)
45. P Wang SG Lloyd H Zeng A Bonen JC Chatham 2005 Impact of altered substrate utilization on cardiac function in isolated hearts from Zucker diabetic fatty rats Am J Physiol Heart Circ Physiol 288 H2102 H2110 15615844 10.1152/ajpheart.00935.2004 1:CAS:528:DC%2BD2MXktlShtr0%3D (Pubitemid 40604093)
46. DSH Bell 2003 Diabetic cardiomyopathy Diabetes Care 26 249 2951 10.2337/diacare.26.1.249 (Pubitemid 36929030)
47. AD Struthers AD Morris 2002 Screening for and treating left-ventricular abnormalities in diabetes mellitus: a new way of reducing cardiac deaths Lancet 359 1430 1432 11978359 10.1016/S0140-6736(02)08358-7 (Pubitemid 34442390)
48. RB Devereux MJ Roman M Paranicas MJ O'Grady ET Lee TK Welty, et al. 2000 Impact of diabetes on cardiac structure and function: the Strong Heart Study Circulation 101 2271 2276 10811594 1:STN:280:DC%2BD3c3ntFyhsw%3D%3D (Pubitemid 30317129)
49. A Vered A Battler P Segal D Liberman Y Yerashami M Berezin, et al. 1984 Exercise-induced left ventricular dysfunction in young men with asymptomatic diabetes mellitus (diabetic cardiomyopathy) Am J Cardiol 54 6 633 637 6475785 10.1016/0002-9149(84)90263-7 1:STN:280:DyaL2czgtl2htQ%3D%3D (Pubitemid 14073258)
50. S Carugo C Giannattasio I Calchera F Paleari MG Gorgoglione A Grappiolo P Gamba G Rovaris M Failla G Mancia 2001 Progression of functional and structural cardiac alterations in young normotensive uncomplicated patients with type 1 diabetes mellitus J Hypertens 19 1675 1680 11564989 10.1097/00004872-200109000- 00021 1:CAS:528:DC%2BD3MXmslSqs78%3D (Pubitemid 32783787)
51. CM Schannwell M Schneppenheim S Perings G Plehn BE Strauer 2002 Left ventricular diastolic dysfunction as an early manifestation of diabetic cardiomyopathy Cardiology 98 33 39 12373045 10.1159/000064682 1:STN:280:DC%2BD38nhsFertA%3D%3D (Pubitemid 35375651)
52. P Di Bonito S Cuomo N Moio G Sibilio D Sabatini S Quattrin B Capaldo 1996 Diastolic dysfunction in patients with non-insulin-dependent diabetes mellitus of short duration Diabet Med 13 321 324 9162606 10.1002/(SICI)1096-9136(199604) 13:4<321::AID-DIA3>3.0.CO;2-7 1:STN:280:DyaK2s%2FhtlSjsg%3D%3D (Pubitemid 26141696)
53. H Von Bibra IS Thrainsdottir A Hansen V Dounis K Malmberg L Rydén 2005 Tissue Doppler imaging for the detection and quantitation of myocardial dysfunction in patients with type 2 diabetes mellitus Diab Vasc Dis Res 2 1 24 30 10.3132/dvdr.2005.002 (Pubitemid 40333201)
54. A Stefanidis S Bousboulas J Kafatis K Baroutsi P Margos K Komninos, et al. 2009 Left ventricular anatomical and functional changes with ageing in type 2 diabetic adults Eur J Echocardiogr 10 5 647 653 19339263 10.1093/ejechocard/ jep026
55. C Jarnert L Landstedt-Hallin K Malmberg A Melcher J Ohrvik H Persson, et al. 2009 A randomized trial of the impact of strict glycaemic control on myocardial diastolic function and perfusion reserve: a report from the DADD (Diabetes mellitus and Diastolic Dysfunction) study Eur J Heart Fail 11 1 39 47 19147455 10.1093/eurjhf/hfn018
56. H von Bibra A Hansen V Dounis T Bystedt K Malmberg L Rydén 2004 Augmented metabolic control improves myocardial diastolic function and perfusion in patients with non-insulin dependent diabetes Heart 90 12 1483 1484 10.1136/hrt.2003.020842 (Pubitemid 39626336)
57. AK Bose MM Mocanu RD Carr CL Brand DM Yellon 2005 Glucagon like peptide-1 can directly protect the heart against ischemia/reperfusion injury Diabetes 54 146 151 15616022 10.2337/diabetes.54.1.146 1:CAS:528:DC%2BD2MXhtVWju7k%3D (Pubitemid 40105106)
58. T Zhao P Parikh S Bhashyam H Bolokoglu I Poornima YT Shen, et al. 2006 Direct effects of glucagon-like peptide-1 on myocardial contractility and glucose uptake in normal and post-ischemic isolated rat hearts J Pharmacol Exp Ther 317 1106 1113 16489128 10.1124/jpet.106.100982 1:CAS:528: DC%2BD28Xlt1eqtL8%3D (Pubitemid 43764114)
59. M Debono E Cachia 2007 The impact of cardiovascular autonomic neuropathy in diabetes: is it associated with left ventricular dysfunction? Auton Neurosci 132 1-2 1 7 17197251 10.1016/j.autneu.2006.11.003
60. W Rathmann D Ziegler M Jahnke B Haastert FA Gries 1993 Mortality in diabetic patients with cardiovascular autonomic neuropathy Diabet Med 10 9 820 824 8281726 10.1111/j.1464-5491.1993.tb00173.x 1:STN:280:DyaK2c7gvFSqtQ%3D%3D (Pubitemid 23326833)
61. MF Di Carli D Bianco-Batlles ME Landa A Kazmers H Groehn O Muzik, et al. 1999 Effects of autonomic neuropathy on coronary blood flow in patients with diabetes mellitus Circulation 100 8 813 819 10458716 1:STN:280: DyaK1MzovVehsw%3D%3D (Pubitemid 29398878)
62. R Scognamiglio A Avogaro D Casara C Crepaldi M Marin M Palisi, et al. 1998 Myocardial dysfunction and adrenergic cardiac innervation in patients with insulin-dependent diabetes mellitus J Am Coll Cardiol 31 404 412 9462586 10.1016/S0735-1097(97)00516-0 1:STN:280:DyaK1c7it1Ciug%3D%3D (Pubitemid 28153462)
63. M Chottová Dvoráková J Kuncová U Pfeil GP McGregor J Svíglerová J Slavíková, et al. 1995 Cardiomyopathy in stroptozocin-induced diabetes involves intra-axonal accumulation of calcitonin gene-related peptide and altered expression of its receptor in rats Neuroscience 134 51 58 10.1016/j.neuroscience.2005.03.058
64. L Cai Y Wang G Zhou T Chen Y Song X Li YJ Kang 2006 Attenuation by metallothionein of early cardiac cell death via suppression of mitochondrial oxidative stress results in a prevention of diabetic cardiomyopathy J Am Coll Cardiol 48 1688 1697 17045908 10.1016/j.jacc.2006.07.022 1:CAS:528: DC%2BD28XhtVyit7jI (Pubitemid 44528172)
65. Q Liang EC Carlson RV Donthi PM Kralik X Shen PN Epstein 2002 Overexpression of metallothionein reduces diabetic cardiomyopathy Diabetes 51 174 181 11756338 10.2337/diabetes.51.1.174 1:CAS:528:DC%2BD38Xlt1ehtg%3D%3D (Pubitemid 34517995)
66. S Matsushima S Kinugawa T Ide H Matsusaka N Inoue Y Ohta, et al. 2006 Overexpression of glutathione peroxidase attenuates myocardial remodeling and preserves diastolic function in diabetic heart Am J Physiol Heart Circ Physiol 291 H2237 H2245 16844917 10.1152/ajpheart.00427.2006 1:CAS:528: DC%2BD28Xht1GnsLfN (Pubitemid 44794216)
67. X Shen S Zheng NS Metreveli PN Epstein 2006 Protection of cardiac mitochondria by overexpression of MnSOD reduces diabetic cardiomyopathy Diabetes 55 798 805 16505246 10.2337/diabetes.55.03.06.db05-1039 1:CAS:528: DC%2BD28XisVWisLc%3D (Pubitemid 43343239)
68. D Westermann T Walther K Savvatis M Sobirey A Riad M Bader, et al. 2009 Gene deletion of the kinin receptor B1 attenuates cardiac inflammation and fibrosis during the development of experimental diabetic cardiomyopathy Diabetes 58 6 1373 1381 19276445 10.2337/db08-0329
69. DA Cesario R Brar K Shivkumar 2006 Alterations in ion channel physiology in diabetic cardiomyopathy Endocrinol Metab Clin North Am 35 601 610 16959588 10.1016/j.ecl.2006.05.002 1:CAS:528:DC%2BD28XhtFyhsb7N ix-x (Pubitemid 44321949)
70. XY Zhao SJ Hu J Li Y Mou BP Chen Q Xia 2006 Decreased cardiac sarcoplasmic reticulum Ca2#-ATPase activity contributes to cardiac dysfunction in streptozotocin-induced diabetic rats J Physiol Biochem 62 1 8 16909926 10.1007/BF03165800 1:CAS:528:DC%2BD28XhtlCjs7vE (Pubitemid 44102814)
71. GD Lopaschuk AG Tahiliani RV Vadlamudi S Katz JH McNeill 1983 Cardiac sarcoplasmic reticulum function in insulin- or carnitine-treated diabetic rats Am J Physiol Heart Circ Physiol 245 H969 H976 1:CAS:528:DyaL2cXkvFGntg%3D%3D
72. EE Jweied RD McKinney LA Walker I Brodsky AS Geha MG Massad, et al. 2005 Depressed cardiac myofilament function in human diabetes mellitus Am J Physiol Heart Circ Physiol 289 H2478 H2483 16085678 10.1152/ajpheart.00638.2005 1:CAS:528:DC%2BD28XlslGmug%3D%3D (Pubitemid 41698560)
73. JC Khatter P Sadri M Zhang RJ Hoeschen 1996 Myocardial angiotensin II (Ang II) receptors in diabetic rats Ann N York Acad Sci 793 466 472 10.1111/j.1749-6632.1996.tb33543.x 1:CAS:528:DyaK2sXhtV2nsLg%3D (Pubitemid 26402624)
74. X Liu H Suzuki R Sethi PS Tappia N Takeda NS Dhalla 2006 Blockade of the renin-angiotensin system attenuates sarcolemma and sarcoplasmic reticulum remodeling in chronic diabetes Ann N Y Acad Sci 1084 141 154 17151298 10.1196/annals.1372.003 1:CAS:528:DC%2BD2sXpsFehsw%3D%3D (Pubitemid 47091938)
75. N Yaras A Bilginoglu G Vassort B Turan 2007 Restoration of diabetes-induced abnormal local Ca2# release in cardiomyocytes by angiotensin II receptor blockade Am J Physiol Heart Circ Physiol 292 H912 H920 17012347 10.1152/ajpheart.00824.2006 1:CAS:528:DC%2BD2sXjt1Gnsbk%3D
76. F Fiordaliso I Cuccovillo R Bianchi A Bai M Doni M Salio, et al. 2006 Cardiovascular oxidative stress is reduced by an ACE inhibitor in a rat model of streptozotocin-induced diabetes Life Sci 79 121 129 16445948 10.1016/j.lfs.2005.12.036 1:CAS:528:DC%2BD28XkvVGisrY%3D (Pubitemid 43737057)
77. JW Eaton M Qian 2002 Interactions of copper with glycated proteins: possible involvement in the etiology of diabetic neuropathy Mol Cell Biochem 234 235 135 142 12162426 10.1023/A:1015988817587 (Pubitemid 34777850)
78. M Rota N LeCapitaine T Hosoda A Boni A De Angelis ME Padin-Iruegas, et al. 2006 Diabetes promotes cardiac stem cell aging and heart failure, which are prevented by deletion of the p66shc gene Circ Res 99 44 52 10.1161/01.RES. 0000231289.63468.08 (Pubitemid 44297054)
79. NS Dhallas X Liu V Panagia N Takeda 1998 Subcellular remodeling and heart dysfunction in chronic diabetes Cardiovasc Res 40 2 239 247 10.1016/S0008-6363(98)00186-2 (Pubitemid 28506032)
80. JE Liu C Robbins V Palmieri JN Bella MJ Roman R Fabsitz, et al. 2003 Association of albuminuria with systolic and diastolic left ventricular dysfunction in type 2 diabetes: the Strong Heart Study J Am Coll Cardiol 41 11 2022 2028 12798576 10.1016/S0735-1097(03)00403-0 1:CAS:528:DC%2BD3sXltFGjs7s%3D (Pubitemid 36677126)
81. WJ Paulus C Tschöpe JE Sanderson C Rusconi FA Flachskampf FE Rademakers, et al. 2007 How to diagnose diastolic heart failure: a consensus statement on the diagnosis of heart failure with normal left ventricular ejection fraction by the Heart Failure and Echocardiography Associations of the European Society of Cardiology Eur Heart J 28 20 2539 2550 17428822 10.1093/eurheartj/ehm037 (Pubitemid 47614269)
82. S Yusuf MA Pfeffer K Swedberg CB Granger P Held JJ McMurray, et al. 2003 Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-preserved trial Lancet 362 9386 777 778 13678871 10.1016/S0140-6736(03)14285-7 1:CAS:528:DC%2BD3sXntVGktLg%3D (Pubitemid 37093918)
83. C Tribouilloy D Rusinaru H Mahjoub JM Tartière L Kesri-Tartière S Godard, et al. 2008 Prognostic impact of diabetes mellitus in patients with heart failure and preserved ejection fraction: a prospective 5-year study Heart 94 11 1450 1455 18208832 10.1136/hrt.2007.128769 1:STN:280:DC%2BD1cnmslOgsg%3D%3D
84. V Melenovsky BA Borlaug B Rosen I Hay L Ferruci CH Morell, et al. 2007 Cardiovascular features of heart failure with preserved ejection fraction versus non failing hypertensive left ventricular hypertrophy in the urban Baltimore community: the role of atrial remodeling/dysfunction J Am Coll Cardiol 49 2 198 207 17222731 10.1016/j.jacc.2006.08.050 (Pubitemid 46070209)